Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.412 USD | +0.15% | +3.07% | -29.04% |
04-26 | Exagen Inc. Announces Changes in Board of Directors | CI |
03-18 | Exagen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 54.16M 4.34B | Sales 2025 * | 62.91M 5.04B | Capitalization | 24.51M 1.96B |
---|---|---|---|---|---|
Net income 2024 * | -24M -1.92B | Net income 2025 * | -19M -1.52B | EV / Sales 2024 * | 0.45 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.39 x |
P/E ratio 2024 * |
-1.04
x | P/E ratio 2025 * |
-1.36
x | Employees | 177 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 49.26% |
Latest transcript on Exagen Inc.
1 day | +0.15% | ||
1 week | +3.07% | ||
Current month | -11.19% | ||
1 month | -9.48% | ||
3 months | -27.58% | ||
6 months | -6.48% | ||
Current year | -29.04% |
Managers | Title | Age | Since |
---|---|---|---|
John Aballi
CEO | Chief Executive Officer | 39 | 16/10/22 |
Kamal Adawi
DFI | Director of Finance/CFO | 45 | 31/05/17 |
Ming-Chou Lee
CTO | Chief Tech/Sci/R&D Officer | - | 31/07/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bruce Robertson
BRD | Director/Board Member | 61 | 29/07/19 |
Paul Kim
BRD | Director/Board Member | 56 | 23/07/23 |
Wendy Johnson
BRD | Director/Board Member | 72 | 30/09/20 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 1.412 | +0.15% | 3,601 |
25/04/24 | 1.41 | +2.17% | 17,178 |
24/04/24 | 1.38 | -1.43% | 2,617 |
23/04/24 | 1.4 | 0.00% | 11,155 |
22/04/24 | 1.4 | +2.19% | 6,118 |
Delayed Quote Nasdaq, April 26, 2024 at 09:30 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.04% | 24.51M | |
-14.92% | 84.68B | |
+13.30% | 81.12B | |
+10.92% | 29.4B | |
-12.71% | 16.73B | |
-3.06% | 16.36B | |
-2.63% | 14.92B | |
-31.75% | 11.77B | |
-1.42% | 11.72B | |
+27.44% | 11.71B |
- Stock Market
- Equities
- XGN Stock